Healthcare · Diagnostics Research · NYSE
| Market cap | $12.88B |
|---|---|
| Trailing P/E | 27.0 |
| FCF yield | 3.9% |
| Revenue growth (YoY) | -0.8% |
| EPS growth (YoY) | -0.4% |
| FCF/share growth (YoY) | +7.7% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Charles River Laboratories International, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Jefferson Shreve | House | Buy | $15,001 - $50,000 | May 15, 2025 |
| Rob Bresnahan | House | Buy | $15,001 - $50,000 | Apr 8, 2025 |
| Julie Johnson | House | Buy | $1,001 - $15,000 | Feb 7, 2025 |
| Lois Frankel | House | Sell | $1,001 - $15,000 | Oct 6, 2023 |
| Zoe Lofgren | House | Sell | $1,001 - $15,000 | Sep 13, 2022 |
| Zoe Lofgren | House | Buy | $1,001 - $15,000 | Oct 7, 2021 |
| Susie Lee | House | Sell | $1,001 - $15,000 | Oct 31, 2019 |
| Susie Lee | House | Buy | $1,001 - $15,000 | Sep 1, 2019 |
| Donna Shalala | House | Sell | $1,001 - $15,000 | Jun 30, 2019 |
| Lamar Smith | House | Sell | $1,001 - $15,000 | Oct 1, 2018 |
| Thomas MacArthur | House | Buy | $1,001 - $15,000 | Oct 1, 2018 |
| Thomas MacArthur | House | Buy | $1,001 - $15,000 | Oct 1, 2018 |